PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Avizafone→

Avizafone PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
65617-86-9
Molecular formula
C22H27ClN4O3
Molecular weight
430.9 g/mol
Drug class
Benzodiazepine prodrugwater-soluble diazepam precursor and anticonvulsant
Mechanism of action
A water-soluble prodrug that is hydrolysed to diazepam. Diazepam enhances GABAA receptor-mediated inhibitory neurotransmission by positive allosteric modulation at the benzodiazepine site, producing anticonvulsant, anxiolytic, sedative and muscle-relaxant effects.
Indications / reported uses
  • Developed as an injectable or autoinjector prodrug of diazepam for emergency treatment of seizures, including seizure management in military nerve-agent medical countermeasure protocols. Product availability and current authorisation are limited.

Sources: https://pubchem.ncbi.nlm.nih.gov/#query=avizafone · https://pubmed.ncbi.nlm.nih.gov/?term=avizafone+diazepam+prodrug · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Avizafone PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Avizafone Permitted Daily Exposure (PDE) report (the Avizafone PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Avizafone Occupational Exposure Limit (OEL) report (the Avizafone OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.